References
- Smith G W, McCrone S, Petersen S L, et al. Expression of messenger ribonucleic acid encoding tissue inhibitor of metalloproteinases-2 within ovine follicles and corpora lutea. Endocrinology 1995; 136: 570–6
- Bischof P. Metalloproteinases and regulation of endometrial function. The Endometrium as a Target for Contraception, HM Beier, MJK Harper, K Chwalisz. Springer-Verlag, Heidelberg, Berlin 1997; 123–36
- Morioka N, Zhu C, Brännström M, et al. Mechanisms of mammalian ovulation. Prog Clin Biol Res 1989; 294: 65–85
- Woessner JF, Jr. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995; 248: 510–28
- Van der Zee E, Everts V, Hoeben K, et al. Immunolocalisation of collagenase in rabbit periosteal tissue explants and extraction of the enzyme. The effect of the cytokines IL-1α and EGF. J Cell Sci 1994; 107: 1047–53
- Murdoch W J, McCormick R J. Enhanced degradation of collagen within apical vs. basal wall of ovulatory ovarian follicles. Am J Ph?siol 1992; 233: E221–5
- Puistola U, Westerlund A, Kauppila A, et al. Regulation of 72-kDa type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosa-lutein cells. Fertil Steril 1995; 64: 81–7
- Woessner JF, Jr, Morioka N, Zhou C, et al. Connective tissue breakdown in ovulation. Steroids 1989; 54: 491–9
- Reich R, Daphna-Iken D, Chun S Y, et al. Preovulatory changes in ovarian expression of collagenases and tissue metalloproteinase inhibitor messenger ribonucleic acid: role of eiconasoids. Endocrinology 1991; 129: 1869–75
- Postawski K, Rechberger T, Skorupski P, et al. Extracellular matrix remodelling within the normal human ovarian capsule. Eur J Obstet Gynecol Reprod Biol 1996; 67: 173–7
- Woessner JF, Jr. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995; 248: 510–28
- Dean D D, Woessner JF, Jr. A sensitive, specific assay for tissue collagenase using telopeptide-free [3H]acetylated collagen. Anal Biochem 1985; 148: 174–81
- Stegemann H, Stalder K H. Determination of hydroxyproline. Clin Chim Acta 1967; 18: 267–73
- Neuman R E, Logan M A. The determination of hydroxyproline. J Biol Chem 1950; 184: 295–319
- Van der Zee E. Cytokines. Modulate the Intracellular and Extracellular Pathways of Collagen Degradation. Academisch Proefschrift, Universiteit van Amsterdam. Ervin van der Zec, Amsterdam 1994
- He C, Wilhelm S M, Pentland A P, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 2632–6
- Reich R, Miskin R, Tsafriri A. Follicular plasminogen activator: involvement in ovulation. Endocrinology 1985; 116: 516–21
- Matrisian L M, Hogan B L. Growth factor-regulated proteases and extracellular matrix remodeling during mammalian development. Curr Top Dev Biol 1990; 24: 219–59
- Chegini N, Flanders K C. Presence of transforming growth factor-beta and their selective cellular localization in human ovarian tissue of various reproductive stages. Endocrinology 1992; 130: 1707–15
- Chegini N, Williams R S. Immunocytochemical localization of transforming growth factors (TGFs) TGF-alpha and TGF-beta in human ovarian tissues. J Clin Endocrinol Metab 1992; 74: 973–80
- Magoffin D A, Hubert-Leslie D, Zachow R J. Estradiol-17-beta, insulin-like growth factor-I, and luteinizing hormone inhibit secretion of transforming growth factor beta by rat ovarian theca-interstitial cells. Biol Reprod 1995; 53: 627–35
- Hillier S G. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994; 9: 188–91
- Shibata S. Effect of RU486 on collagenolytic enzyme activities in immature rat ovary. Nippon Sanka Fujinka Gakkai Zasshi 1990; 42: 136–42
- Postawski K, Jakimiuk A J, Rechberger T, et al. Interleukin-8 tissue levels in human tunica albuginea of ovarian follicles. Acta Obstet Gynaecol Scand 1997; 76(Suppl 167)5, 17
- Li J, Ireland G W, Farthing P M, et al. Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation. J Invest Dermatol 1996; 106: 661–6
- Okamura H. Control mechanisms of ovarian function. Nippon Sanka Fujinka Gakkai Zasshi 1991; 43: 890–6
- Kamat B R, Brown L F, Manseau E J, et al. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 1995; 146: 157–65
- Chang R J, Plouffe L, Jr, Schaffer K. Physiology of the menopause. Comprehensive Management of Menopause, J Lorrain, L Plouffe, Jr, V Ravnikar, L Speroff, N Watts. Springer-Verlag, New York 1994; 3–13